PATENT CLAIM ANALYSIS

Application Number: 16225920
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "210200"]

Abstract:
The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts thereof, as well as processes for their manufacture, pharmaceutical compositions comprising them, and their use as medicaments.

Claim (Index 21):
The compound of  claim 1 , wherein each R 5  is independently selected from hydroxy, methoxy, NH 2 , NHCH 3 , N(CH 3 ), N(CH 2 CH 3 ) 2 , NH(CH 2 COOH), NH(COO-tert-butyl), N(CH 3 )(CH 2 COOH), N(CH 2 COOH)(COO-tert-butyl), NH(oxetanyl), COOH, COOCH 3 , CONH 2 , CONH(CH 3 ), CONH(CH 2 CH 2 N(CH 3 ) 2 , CONH(CH 2 CH 2 OH), CONH(CH 2 CH 2 CH 2 OCH 3 ), CONH(CH(CH 3 ) 2 ), CON(CH 3 ) 2 , SO 2 -methyl, SO 2 \u2014NH 2 , azetidinyl, pyrrolidinyl, piperazinyl, morpholinyl and imidazolyl;\n wherein methoxy is optionally substituted by COOH, COOCH 2 CH 3 , CONH(CH 3 ), or CON(CH 3 ) 2 ; wherein azetidinyl, pyrrolidinyl, piperazinyl, morpholinyl and imidazolyl are optionally substituted with one or two substituents selected from methyl, trifluoromethyl, hydroxy, methoxy, COOH, COOCH 3 , and COOCH 2 CH 3 .

Metadata:
- Claim Count in Document: 99.0
- Percentile: 98.0
- Lexical Diversity: 1.15625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12845045', '14458062', '13272079', '13519872', '12815800']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7642615309918164
- 35 USC 102 Novelty (BERT): 0.5195807400295223
- Combined Prediction Score: 0.739793451895587
- Mean Citation Score: 282.042748
- Max Citation Score: 286.458
- Similarity Product: 202.1639397432804

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test